Pinnacles Medical: Pioneer of smart testing, building an unattended laboratory, has received investment from several leading medical funds

Ding Wei, the founder of Pinnacles Medical, has more than 20 years of experience in the global field of in vitro diagnostics, and has extensive experience in product development, strategic mergers and acquisitions, sales management, etc. President of Kehua Biotechnology Co., Ltd.

With his deep experience in the in vitro diagnostic market, Ding Wei has a particularly keen sense of industry trends. "China's in vitro diagnostic industry has experienced changes from open reagents, to a closed system of instruments + reagents, to the rise of laboratory assembly lines in recent years. Assembly lines, especially national production lines, are an important step in the industry, but not the ultimate, wisdom Testing will be a new outlet for in vitro diagnostics after the assembly line.

Pinnacles Medical focuses on the in vitro diagnostic smart inspection sector. Starting from clinical needs, it integrates traditional diagnosis and cross-border technologies to provide an overall solution for smart inspection. It is deploying smart inspection robots, assembly lines, bioimmune and molecular diagnostic products. Human-attended laboratories help the laboratory to improve the accuracy of test results, reduce costs, shorten reporting time and optimize management.

Now, the company has won the favor of leading investment institutions such as Lilly Asia Fund, ZhenFund, Oriental Fortune, Qingsong Capital, and Vertex Capital. It has received nearly 400 million yuan in financing within two years of its establishment.




Realize extreme automation, information management integration, and assist clinical decision-making


The National Health and Medical Commission requires that it is necessary to summarize the practice of hospital informatization construction, establish a "trinity" smart hospital system of medical treatment, service, and management, and apply artificial intelligence, big data, cloud computing, and Internet of Things technologies to medical scenarios to improve all aspects. Efficiency and quality of healthcare services. As an important part of smart hospitals, smart testing has grown rapidly with policy support. In recent years, the demand for intelligent solutions in clinical laboratory departments has also risen rapidly.

Ding Wei, founder of Pinnacles Medical, believes that smart testing has three important features: extreme automation, integrated information management, and clinical decision-making assistance.

The existing assembly line solves 60%-70% of the automation problems in the laboratory, but there is still room for improvement in the degree of automation during the process of sample collection, entry into the laboratory, verification, sorting, distribution to different test centers, and testing. . In the post-processing link, the existing automated management is represented by smart refrigerators, which are expensive and lack flexibility.

The so-called extreme automation is to realize the automation of the whole process from sample to result and laboratory management.

In addition, the laboratory information management system currently used by the laboratory has the problem of information fragmentation. Different equipment and systems need to be integrated and intervened, and the integration of information management has not yet been realized.

The last is to assist clinical decision-making. In the future, the laboratory department will not only provide a simple result report for the clinic, but also provide relevant information for interpretation and multi-marker trend analysis to facilitate clinical decision-making.

Ding Wei said: "Intelligent inspection is born in response to the times, and what needs to be solved is how to find a commercial model that can be implemented. Past experience shows that the independent layout of intelligent software is more resistant to commercialization in the laboratory. The solution of Pinnacles Medical is All-round layout in equipment, reagents, and software. "

The core team of Pinnacles Medical comes from excellent domestic and foreign enterprises, and has built a complete team covering the upper, middle and lower reaches, including instruments, reagents, and software. The company is developing and gradually launching laboratory robots, software, assembly lines, high-speed bio-analyzers and other types of products to provide a complete solution for intelligent testing. At present, Pinnacles Medical has developed a variety of robot products such as specimen transport robots, and has completed installations in dozens of tertiary hospitals. The assembly line and its supporting products will also be launched soon.

Ding Wei positioned Pinnacles Medical as a pioneer of smart inspection, "We adopt the Build-Buy-Collaborate model, with independent research and development as the core, strategic mergers and acquisitions, and external cooperation as supplements, and quickly improve the business layout, aiming to create unattended laboratory ."



China is expected to

  Global Wisdom Inspection Segment Curve Overtaking


In vitro diagnosis is a good time for a hundred flowers to bloom. According to Frost & Sullivan's forecast, the Chinese market will reach 195.7 billion yuan in 2024, and the compound growth rate from 2019 to 2024 will be about 17.8%, continuing to maintain a rapid growth trend.

At present, there are several major trends in in vitro diagnostics. First, emerging technologies are emerging in various subdivisions, including fourth-generation sequencing, microfluidics, molecular POCT, and mass spectrometry; Laboratory departments are moving towards home, customs and other out-of-hospital scenarios; third, the detection objects have expanded to normal people, and early cancer screening has become a popular track; fourth, excellent companies are going overseas in batches for global deployment.

In general, the in vitro diagnostic industry is full of vitality, and smart testing will be an important force to push the laboratory to a new peak. Ding Wei believes: "The gap between domestic laboratories and foreign countries in terms of specimen volume, degree of automation, and hardware and software configuration will be narrowed, and they will achieve cutting-edge and internationalization."

Of course, at present, smart testing is still a new thing in the world. Although international giants have noticed the opportunity of smart testing, they have not yet launched a complete solution. Chinese companies have opportunities.

"In the past five years, China's industrial robots and AI technology have made great breakthroughs, and the recognition and acceptance of smart inspection by the top tertiary hospitals in China have also been relatively high. Benefiting from this, China's smart inspection will usher in a rapid development . Development, to achieve overtaking in curves. Domestic enterprises will be an important force in providing smart inspection solutions.” Ding Wei said.

In the future, driven by the wave of smart testing, Pinnacles Medical will take smart testing as its core competitiveness and aim to build an in vitro diagnostic platform enterprise.